![The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration - ScienceDirect The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2059702921000132-gr1.jpg)
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration - ScienceDirect
![The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series - ESMO Open The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0ca1ee8e-770d-4a4a-bc8b-189a3908684d/gr1_lrg.jpg)
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series - ESMO Open
![National Center for Cancer Immune Therapy CCIT-DK on Twitter: "Congratulations to @DoniaMarco for completing the @myESMO Leaders Generation Programme #LGP18 at #esmo18 https://t.co/xdTAOfqmbh" / Twitter National Center for Cancer Immune Therapy CCIT-DK on Twitter: "Congratulations to @DoniaMarco for completing the @myESMO Leaders Generation Programme #LGP18 at #esmo18 https://t.co/xdTAOfqmbh" / Twitter](https://pbs.twimg.com/media/Dp9ELL_WkAAqR5G.jpg:large)
National Center for Cancer Immune Therapy CCIT-DK on Twitter: "Congratulations to @DoniaMarco for completing the @myESMO Leaders Generation Programme #LGP18 at #esmo18 https://t.co/xdTAOfqmbh" / Twitter
![Stream episode ESMO Leaders Generation Programme – an alumni insight by BMJ talk medicine podcast | Listen online for free on SoundCloud Stream episode ESMO Leaders Generation Programme – an alumni insight by BMJ talk medicine podcast | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-000230606779-eifkkb-t500x500.jpg)
Stream episode ESMO Leaders Generation Programme – an alumni insight by BMJ talk medicine podcast | Listen online for free on SoundCloud
![ESMO: In landmark win, Novartis' Kisqali extends breast cancer survival by one year. Can it challenge Pfizer's Ibrance? | Fierce Pharma ESMO: In landmark win, Novartis' Kisqali extends breast cancer survival by one year. Can it challenge Pfizer's Ibrance? | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1631888453/KISQALI.jpg/KISQALI.jpg?VersionId=z8MNkkxR0NDWpo0UWDPq_nc48qMKO_Zb)